Folate deficiency in premature infants.

Response of low birthweight infant to treatment with folic acid. Arch Dis Child (1971) 1.30

Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 0.96

Folic acid in low birthweight infants. Arch Dis Child (1974) 0.94

Effect of folic acid treatment on premature infants. Arch Dis Child (1972) 0.91

The 'early anaemia'; its relation to postnatal growth rate, milk feeding, and iron availability. Experimental study in rabbits. Arch Dis Child (1973) 0.91

Influence of folic acid on birthweight and growth of the erythroblastotic infant. II. Growth during the first year. Arch Dis Child (1977) 0.88

Blood formation in infancy. Arch Dis Child (1979) 0.75

Folic and folinic acid in maternal and foetal blood. Br J Haematol (1960) 1.79

Megaloblastic anaemia and whole-blood folate levels in premature infants. Lancet (1966) 1.76

Folate state of premature infants. Arch Dis Child (1969) 1.67

Megaloblastic anemia of infancy. Adv Pediatr (1953) 1.52

Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J (1970) 1.47

Juvenile familial megaloblastic anaemia due to selective malabsorption of vitamin B-12. A family study and a review of the literature. Q J Med (1966) 1.32

Folic acid status in normal infants during the first year of life. Arch Dis Child (1966) 1.31

The labile folate of milk. Am J Clin Nutr (1966) 1.30

Isolated defect of folic acid absorption associated with mental retardation and cerebral calcification. Blood (1969) 1.25

FOLIC ACID DEFICIENCY AND PREMATURITY. J Pediatr (1964) 1.22

PERNICIOUS ANEMIA IN CHILDHOOD. N Engl J Med (1965) 1.21

Infection as cause of folic acid deficiency and megaloblastic anemia; experimental induction of megaloblastic anemia by turpentine abscess. AMA Am J Dis Child (1952) 1.19

STUDIES ON FOLIC ACID IN INFANCY. Pediatrics (1964) 1.16

Megaloblastic anemia of infancy secondary to maternal pernicious anemia. N Engl J Med (1966) 1.09

Folate activity in human milk. Br J Nutr (1965) 0.99

Vitamin E-responsive macrocytic anemia in protein-calorie malnutrition. Measurements of vitamin E, folic acid, vitamin C, vitamin B12 and iron. Am J Clin Nutr (1966) 0.92

Megaloblastic anemia and mental retardation associated with hyperfolic-acidemia: probably due to N5 methyltetrahydrofolate transferase deficiency. Tohoku J Exp Med (1967) 0.87

Hereditary orotic aciduria. I. A new case with family studies. Pediatrics (1968) 0.85

Goat's milk and megaloblastic anaemia of infancy: A report of three cases and a survey of the folic acid activity of some New Zealand milks. N Z Med J (1966) 0.80

A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68

Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol (1966) 4.44

Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50

Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11

Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78

Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54

Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29

Folic acid fortification and cancer risk. Lancet (2007) 2.17

Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15

Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11

Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09

Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet (1973) 2.01

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01

Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99

The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94

Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91

Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91

Folate deficiency and neurological disease. Lancet (1965) 1.85

Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82

Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81

Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72

Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70

Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61

Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis. Arch Dermatol (1969) 1.60

Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia (2002) 1.60

Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58

Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55

The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55

The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54

Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54

Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53

Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53

Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50

Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45

Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45

Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42

Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41

Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41

Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37

Absorption of crystalline folic acid in man. Lancet (1968) 1.35

Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35

Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34

Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34

Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33

Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31

Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30

High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30

Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29

Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29

Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28

Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) (1987) 1.28

Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28

Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25

Studies of folate uptake by phytohaemagglutinin-stimulated lymphocytes. Br J Haematol (1970) 1.25

Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii. Br J Haematol (1972) 1.23

Indices of granulocyte activity in inflammatory bowel disease. Gut (1974) 1.21

Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20

Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Lancet (1973) 1.20

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis (1993) 1.19

1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet (1987) 1.19

Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17

High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15

Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood (1983) 1.15

Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. J Clin Pathol (1982) 1.14

Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol (1999) 1.13

Absorption of vitamin B 12 by the guinea-pig. I. Subcellular localization of vitamin B 12 in the ileal enterocyte during absorption. Br J Haematol (1970) 1.13

Heavy metal intoxication from homeopathic and herbal remedies. Postgrad Med J (1994) 1.12

The effect of deoxyuridine, vitamin B12, folate and alcohol on the uptake of thymidine and on the deoxynucleoside triphosphate concentrations in normal and megaloblastic cells. Br J Haematol (1978) 1.12

Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11

The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes. Biochem Pharmacol (1975) 1.10

The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica (2001) 1.10

Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet (1977) 1.08

Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload. Br J Haematol (1995) 1.07

The excretion of foriminoglutamic acid and urocanic acid after partial gastrectomy. Lancet (1966) 1.07

The subcellular localization of pteroyl polyglutamate hydrolase and folate in guinea pig intestinal mucosa. Biochim Biophys Acta (1969) 1.07

Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol (1996) 1.07

Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders. Br J Haematol (1971) 1.06

Anaemia in adult coeliac disease. Clin Gastroenterol (1974) 1.06

Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci (1982) 1.04

Infection with Yersinia enterocolitica in patients with iron overload. Br Med J (Clin Res Ed) (1986) 1.04

The effect of vitamin B12 deficiency on methylfolate metabolism and pteroylpolyglutamate synthesis in human cells. Clin Sci Mol Med (1974) 1.04

The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia (2006) 1.04

Hepatic iron clearance from serum in treated hemochromatosis. Gastroenterology (1978) 1.04

Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies. Br J Haematol (1990) 1.03

Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators. Br J Haematol (1995) 1.03

Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia. Leuk Lymphoma (1996) 1.02

Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol (1997) 1.02

High serum-folate levels in intestinal blind-loop syndrome. Lancet (1966) 1.02

Detection of leukaemic lymphoblasts in CSF by immunofluorescence for terminal transferase. Lancet (1980) 1.02

Endocrine abnormalities in thalassemia. Ann N Y Acad Sci (1990) 1.02

Alpha-interferon therapy for essential thrombocythaemia. Lancet (1988) 1.02

Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: a multiparameter analysis of 300 cases. Br J Haematol (1980) 1.01

Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia (1991) 1.01

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. Blood (1989) 1.01

Value of serum ferritin estimation in sickle cell anaemia. Arch Dis Child (1978) 1.01

Hereditary abnormal transcobalamin II previously diagnosed as congenital dihydrofolate reductase deficiency. N Engl J Med (1984) 1.01

Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol (1997) 1.01

Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. J Immunol (1982) 1.01